Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection

Insaf Fadl Khalil, Ulla Abildrup, Lene H Alifrangis, Deogratius Maiga, Michael Alifrangis, Lotte Hoegberg, Lasse Steenbock Vestergaard, Ola Per-Eric Persson, Nyagonde Nyagonde, Martha M Lemnge, Thor Grundtvig Theander, Ib C Bygbjerg

16 Citationer (Scopus)


Artemether-lumefantrine (ARM-LUM) has in recent years become the first-line treatment for uncomplicated malaria in many Sub-Saharan African countries. Vigorous monitoring of the therapeutic efficacy of this treatment is needed. This requires high-quality studies following standard protocols; ideally, such studies should incorporate measurement of drug levels in the study patients to exclude the possibility that insufficient drug levels explain an observed treatment failure. Several methods for measuring lumefantrine (LUM) in plasma by HPLC are available; however, several of these methods have some limitations in terms of high costs and limited feasibility arising from large required sample volumes and demanding sample preparation. Therefore, we set out to develop a simpler reversed phase high performance liquid chromatography (RP-HPLC) method based on UV detection for simultaneous measurement of LUM and its major metabolite the desbutyl LUM (DL) in plasma. Halofantrine was used as an internal standard. Liquid-liquid extraction of samples was carried out using hexane-ethyl acetate (70:30, v/v). Chromatographic separation was carried out on a Synergi Polar-RP column (250 mm × 300 mm, particle size 4 μm). The mobile phase consisted of acetonitrile-0.1M ammonium acetate buffer adjusted to pH 4.9 (85:15%, v/v). Absorbance of the compounds was monitored at 335 nm using a reference wavelength of 360 nm. Absolute extraction recovery for LUM and DL were 88% and 90%, respectively. Inter- and intraday coefficients of variation for LUM and DL were ≤ 10%. The lower limits of quantification for LUM and DL were 12.5 and 6.5 ng/ml, respectively. After validation, the methodology was transferred to a local laboratory in Tanga Tanzania and samples from a small subset of malaria patients were analysed for LUM. The method appears to be applicable in settings with limited facilities.
TidsskriftJournal of Pharmaceutical and Biomedical Analysis
Udgave nummer1
Sider (fra-til)168-72
Antal sider5
StatusUdgivet - 5 jan. 2011


Dyk ned i forskningsemnerne om 'Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection'. Sammen danner de et unikt fingeraftryk.